CVR: 35234748
DKK 47,649,382
Gross profit
Net result: DKK 11,054,004
Nest Egg ApS
CVR · view ownership and management
Director registered: Lars Mark Poulsen
CVR · 01/01/2016
View the full event history
MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity in the 2025 report amounted to DKK 18,033,649.
Source: annual report 2025, Danish Business Authority
The financial health of MACURE PHARMA ApS appears robust, with a notable increase in gross profit and profit over the past few years. In 2025, the company reported a gross profit of 47.6 million DKK and a profit of 11.1 million DKK, reflecting a significant growth trajectory compared to 8.5 million DKK in 2024 and 8.8 million DKK in 2023. Equity has also shown a positive trend, rising from 10.5 million DKK in 2021 to 18.0 million DKK in 2025, indicating a strengthening financial position. However, the lack of disclosed revenue figures raises concerns about transparency and overall market performance. Positioned within the wholesale trade of pharmaceuticals and medical supplies, MACURE PHARMA ApS demonstrates strong margins and profitability, suggesting a solid foothold in its industry.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at drive handelsvirksomhed inden for den farmaceutiske industri.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 47.6 mio. | 11.1 mio. | 162.2 mio. | 18 mio. | 21 | |
| 202401/01/2024 – 31/12/2024 | 39.1 mio. | 8.5 mio. | 202.5 mio. | 15 mio. | 13 | |
| 202301/01/2023 – 31/12/2023 | 24.2 mio. | 8.8 mio. | 170.3 mio. | 14.2 mio. | 13 | |
| 202201/01/2022 – 31/12/2022 | 37.5 mio. | 17.9 mio. | 114.2 mio. | 23.4 mio. | 10 | |
| 202101/01/2021 – 31/12/2021 | 25 mio. | 5 mio. | 100.5 mio. | 10.5 mio. | 6 | |
| 202001/01/2020 – 31/12/2020 | 15.1 mio. | 5.3 mio. | 57.6 mio. | 10.5 mio. | 10 | |
| 201901/01/2019 – 31/12/2019 | 16.3 mio. | 9.2 mio. | 44 mio. | 14.2 mio. | 6 | |
| 201801/01/2018 – 31/12/2018 | 10.3 mio. | 5.3 mio. | 33.9 mio. | 10.5 mio. | 5 | |
| 201701/01/2017 – 31/12/2017 | 14.4 mio. | 8.9 mio. | 25.4 mio. | 12 mio. | 4 | |
| 201601/01/2016 – 31/12/2016 | 13.3 mio. | 9.1 mio. | 22.5 mio. | 5.5 mio. | - | |
| 201501/01/2015 – 31/12/2015 | 680 t. | 407 t. | 11.4 mio. | 823 t. | - | |
| 201401/01/2014 – 31/12/2014 | 214 t. | 66 t. | 3.2 mio. | 417 t. | - |
Compared to 407 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
24 public tenders won
Showing 10 of 24 contracts
See all won contracts on UdbudsScannerSources: TED (the EU tender database) and udbud.dk
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationMACURE PHARMA ApS was founded on 1 May 2013.
MACURE PHARMA ApS is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler (industry code 464610).
MACURE PHARMA ApS had 3 employees in 2018 according to the Danish CVR register.
MACURE PHARMA ApS is owned by Nest Egg ApS.
In 2025, MACURE PHARMA ApS reported a gross profit of DKK 47,649,382.
The management of MACURE PHARMA ApS consists of Mads Renlef Henningsen and Lars Mark Poulsen.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 70204107, new email: [email protected] (September 10, 2026).
As of September 1, 2026, Cedra Godkendt Revisionsaktieselskab has been appointed auditor of MACURE PHARMA ApS.
As of September 1, 2026, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MACURE PHARMA ApS.
MACURE PHARMA ApS has published its annual report for 2025. Gross profit came to DKK 47,649,382, and the net result was DKK 11,054,004.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.296.a" issued by Amgros I/S worth 20,200,000 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.295.a" issued by Amgros I/S worth 46,824,716 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.607.a" issued by Amgros I/S worth 60,481,552 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.601.a" issued by Amgros I/S worth 331,750,548 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.1201.a" issued by Amgros I/S worth 358,514,920 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 2.1301.a" issued by Amgros I/S worth 39,781,779 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 2.1302.b" issued by Amgros I/S worth 161,990,275 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.1241.a" issued by Amgros I/S worth 19,000,000 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.201.a" issued by Amgros I/S worth 286,787,957 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.604.a" issued by Amgros I/S worth 501,367,776 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 2.3.b" issued by Amgros I/S worth 382,769,201 DKK.
MACURE PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 39,051,226, and the net result was DKK 8,495,013.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1314.a" issued by Amgros I/S worth 50,300,001 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.709.a" issued by Amgros I/S worth 145,756,745 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.710.a" issued by Amgros I/S worth 333,000,000 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 2.210.a" issued by Amgros I/S worth 36,886,685 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 2.1310.b" issued by Amgros I/S worth 129,999,998 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.700.a" issued by Amgros I/S worth 313,301,544 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1390.b" issued by Amgros I/S worth 27,640,446 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1200.a" issued by Amgros I/S worth 101,036,383 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1205.a" issued by Amgros I/S worth 73,155,425 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1204.b" issued by Amgros I/S worth 9,670,700 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 1.1202.a" issued by Amgros I/S worth 90,124,932 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2025 2.3.b" issued by Amgros I/S worth 359,770,187 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2024 1.342.b" issued by Amgros I/S worth 16,200,000 DKK.
MACURE PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 24,158,862, and the net result was DKK 8,790,375.
As of November 16, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MACURE PHARMA ApS.
As of November 16, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MACURE PHARMA ApS.
MACURE PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 37,526,784, and the net result was DKK 17,894,545.
MACURE PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 24,981,874, and the net result was DKK 5,047,696.
MACURE PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 15,148,594, and the net result was DKK 5,257,622.
MACURE PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 16,325,244, and the net result was DKK 9,187,713.
MACURE PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 10,257,349, and the net result was DKK 5,335,423.
MACURE PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 14,376,903, and the net result was DKK 8,913,444.
As of March 1, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MACURE PHARMA ApS.
As of February 28, 2018, Din Revisor Frederiksberg P/S Godkendte Revisorer has stepped down as auditor of MACURE PHARMA ApS.
MACURE PHARMA ApS has published its annual report for 2016. Gross profit came to DKK 13,295,545, and the net result was DKK 9,095,436.
MACURE PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 680,373, and the net result was DKK 406,623.
As of January 1, 2016, Lars Mark Poulsen is registered as director of MACURE PHARMA ApS.
MACURE PHARMA ApS has published its annual report for 2014. Gross profit came to DKK 214,151, and the net result was DKK 66,464.
As of January 1, 2015, Din Revisor Frederiksberg P/S Godkendte Revisorer has been appointed auditor of MACURE PHARMA ApS.
As of January 1, 2015, Bogføring Danmark ApS has stepped down as auditor of MACURE PHARMA ApS.
MACURE PHARMA ApS has published its interim report for the period May 1, 2013 – December 31, 2013.
As of May 13, 2014, Bogføring Danmark ApS has been appointed auditor of MACURE PHARMA ApS.
As of March 5, 2014, Mads Renlef Henningsen is registered as adm. dir. of MACURE PHARMA ApS.
As of March 5, 2014, Simon Søberg Jørgensen has stepped down as director of MACURE PHARMA ApS.
As of May 1, 2013, Simon Søberg Jørgensen is registered as director of MACURE PHARMA ApS.
As of May 1, 2013, Nest Egg ApS is registered as an owner of MACURE PHARMA ApS with an ownership share of 100%.
MACURE PHARMA ApS was founded on May 1, 2013.
Companies in the same industry and area
CVR 33860463
CVR 39762560
CVR 39807114
CVR 40975179
CVR 40975519
